Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 47

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 47
---
───────────────────────────────

96

  (5)      Consists of 15,500 ordinary shares issuable upon exercise of options that are currently exercisable or exercisable within 60 days            
           of March 17, 2025, of which options to purchase the following number of shares expire on the following dates, respectively: 1,000 on August  
           10, 2026, 250 on August 8, 2027,250 on August 6, 2028, 250 on September 23, 2029, 250 on September 22, 2030, 3,600 on September 1, 2031,     
           3,600 on September 15, 2032, 3,600 on May 11, 2033 and 2,700 on June 13, 2034. The weighted average exercise price of these options is       
           NIS 63.12 per ordinary share.                                                                                                                
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (6)      Consists of 4,950 ordinary shares issuable upon exercise of options that are currently exercisable or exercisable within 60 days                
           of March 17, 2025, of which options to purchase the following number of shares expire on the following dates, respectively: 1,800 on September  
           15, 2032, 1,800 on May 11, 2033 and 1,350 on June 13, 2034. The weighted average exercise price of these options is NIS 28.42 per ordinary      
           share.                                                                                                                                          
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (7)      Consists of 7,450 ordinary shares issuable upon exercise of options that are currently exercisable or exercisable within 60 days            
           of March 17, 2025, of which options to purchase the following number of shares expire on the following dates, respectively: 2,500 on April  
           20, 2030, 1,800 on September 15, 2032, 1,800 on May 11, 2033 and 1,350 on June 13, 2034. The weighted average exercise price of these       
           options is $8.90 per ordinary share.